Detalhe da pesquisa
1.
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.
Ann Neurol
; 95(4): 720-732, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38086777
2.
Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report.
BMC Neurol
; 22(1): 185, 2022 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585528
3.
Classification of neurological diseases using multi-dimensional CSF analysis.
Brain
; 144(9): 2625-2634, 2021 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33848319
4.
Status of clinical research in neurology in Germany-A national survey.
Eur J Neurol
; 28(5): 1446-1452, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539600
5.
[Neuromyelitis Optica Spectrum Disorders - Present Insights and Recent Developments]. / Neuromyelitis-optica-Spektrum-Erkrankungen alte und neue Entwicklungen.
Fortschr Neurol Psychiatr
; 89(10): 516-530, 2021 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-34666391
6.
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories.
Sci Transl Med
; 16(740): eade8560, 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38536936
7.
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients.
Clin Transl Sci
; 15(7): 1606-1612, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35213793
8.
Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 8(6)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34667129
9.
An enigmatic case of cortical anopsia: Antemortem diagnosis of a 14-3-3 negative Heidenhain-variant MM1-sCJD.
Prion
; 14(1): 24-28, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31880189
10.
Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosis.
J Neuroimmunol
; 341: 577171, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007787
11.
Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study.
Front Immunol
; 9: 1560, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30050529